Quarterly Transactions Made in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX). The information is specifically focused on institutions that hold shares of Lineage Cell Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 4,982,553 | 3,338,788 | 8,321,341 | 3,185,526 | 196,483 | 3,382,009 | 4,939,332 | |
| Q4 2021 | 3,541,790 | 1,923,047 | 5,464,837 | 5,873,127 | 912,993 | 6,786,120 | -1,321,283 | |
| Q1 2022 | 2,787,557 | 320,301 | 3,107,858 | 2,947,645 | 1,423,980 | 4,371,625 | -1,263,767 | |
| Q2 2022 | 2,537,926 | 3,640,646 | 6,178,572 | 11,920,285 | 2,183,427 | 14,103,712 | -7,925,140 | |
| Q3 2022 | 1,011,446 | 634,977 | 1,646,423 | 1,731,071 | 0 | 1,731,071 | -84,648 | |
| Q4 2022 | 1,569,857 | 778,526 | 2,348,383 | 1,561,279 | 150 | 1,561,429 | 786,954 | |
| Q1 2023 | 5,334,594 | 588,832 | 5,923,426 | 434,117 | 162 | 434,279 | 5,489,147 | |
| Q2 2023 | 11,249,800 | 1,473,855 | 12,723,655 | 4,255,654 | 0 | 4,255,654 | 8,468,001 | |
| Q3 2023 | 2,370,438 | 204,752 | 2,575,190 | 679,432 | 0 | 679,432 | 1,895,758 | |
| Q4 2023 | 2,095,515 | 282,715 | 2,378,230 | 3,005,803 | 0 | 3,005,803 | -627,573 | |
| Q1 2024 | 11,038,939 | 8,493,962 | 19,532,901 | 1,848,435 | 0 | 1,848,435 | 17,684,466 | |
| Q2 2024 | 4,802,911 | 220,598 | 5,023,509 | 3,288,072 | 0 | 3,288,072 | 1,735,437 | |
| Q3 2024 | 1,884,101 | 171,962 | 2,056,063 | 1,683,019 | 0 | 1,683,019 | 373,044 | |